Carregant...
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown to enhance the therapeutic effects of cancer chemotherapy and also to enhance...
Guardat en:
| Publicat a: | Asian Pac J Cancer Prev |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
West Asia Organization for Cancer Prevention
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982677/ https://ncbi.nlm.nih.gov/pubmed/31653148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.3007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|